Latanoprost Clinical Trials

• Combigan Ophthalmic Solution(Brimonidine 0.2% and Timolol 0.5%)With Latanoprost Compared With Latanoprost Monotherapy
  ClinicalTrials.gov Identifier: NCT00442312 - Active, not recruiting
  Glaucoma
  
• Brimonidine 0.1% Versus Brinzolamide 1% as Adjunctive Therapy to Latanoprost 0.005%
  ClinicalTrials.gov Identifier: NCT00440141 - Active, not recruiting
  Glaucoma; Ocular Hypertension
  
• Comparison of Latanoprost Vs. Timolol
  ClinicalTrials.gov Identifier: NCT00579969 - Recruiting
  Glaucoma
  
• Results of Mass Switch From Latanoprost to Travoprost
  ClinicalTrials.gov Identifier: NCT00347126 - Recruiting
  Glaucoma
  
• Efficacy Study of Latanoprost and Bimatoprost Solutions in Promoting Eyelash Growth in Patients With Alopecia Areata
  ClinicalTrials.gov Identifier: NCT00187577 - Active, not recruiting
  Alopecia Areata
  
• Bimatoprost 0.03% Versus Travoprost 0.004% in Patients Currently on Latanoprost 0.005%
  ClinicalTrials.gov Identifier: NCT00440011 - Recruiting
  Glaucoma; Ocular Hypertension
  
• Comparison of Bimatoprost and Latanoprost in Patients With Chronic Angle-Closure Glaucoma: A Randomized Cross-Over Study
  ClinicalTrials.gov Identifier: NCT00567788 - Active, not recruiting
  Glaucoma, Angle-Closure
  
• Effect of Age on Latanoprost 0.005% in Patients With Glaucoma
  ClinicalTrials.gov Identifier: NCT00224289 - Recruiting
  Glaucoma
  
• A Phase 2, Dose-Finding Study Comparing the Safety and Efficacy of Latanoprost to a Novel Treatment for Glaucoma
  ClinicalTrials.gov Identifier: NCT00441883 - Recruiting
  Primary Open Angle Glaucoma; Ocular Hypertension; Pigmentary Glaucoma; Pseudoexfoliative Glaucoma
  
• A safety and efficacy study of Travoprost 0.004% compared to Latanoprost 0.005% in patients with open-angle glaucoma(OAG) or ocular hypertension(OHT)
  ClinicalTrials.gov Identifier: NCT00051142 - Completed
  Glaucoma, Open-Angle; Ocular Hypertension
  
• A Single Dose Comfort Comparison of Travoprost Bak Free 0.004% in One Eye Versus Latanoprost 0.005% in the Opposite Eye in Patients With Primary Open-Angle Glaucoma or Ocular Hypertension
  ClinicalTrials.gov Identifier: NCT00527592 - Recruiting
  Open-Angle Glaucoma; Ocular Hypertension
  
• A safety and efficacy study of Travoprost 0.004% compared to Latanoprost 0.005% in patients with chronic angle-closure glaucoma
  ClinicalTrials.gov Identifier: NCT00051181 - Completed
  Glaucoma, Angle-Closure; Ocular Hypertension
  
• A Study of the Safety and Efficacy of Bimatoprost Compared With Latanoprost in Patients With Glaucoma or Ocular Hypertension
  ClinicalTrials.gov Identifier: NCT00541242 - Not yet recruiting
  Ocular Hypertension, Glaucoma
  
• Latanoprost Versus Fotil
  ClinicalTrials.gov Identifier: NCT00304785 - Completed
  Open-Angle Glaucoma; Ocular Hypertension
  
• Efficacy of Bimatoprost 0.03% in Patients Who Are Low-Responders to Latanoprost
  ClinicalTrials.gov Identifier: NCT00347841 - Completed
  Glaucoma
  
• Brimonidine Purite 0.15% Versus Dorzolamide 2% Used as Adjunctive Therapy to Latanoprost
  ClinicalTrials.gov Identifier: NCT00348400 - Completed
  Glaucoma
  
• 24-Hour IOP Control With Dorzolamide/Timolol and Latanoprost/Timolol Fixed Combination in Open-Angle Glaucoma
  ClinicalTrials.gov Identifier: NCT00397241 - Completed
  Open-Angle Glaucoma
  
• Xalacom And Combination Of Unfixed Latanoprost And Timolol In Subjects With Open-Angle Glaucoma Or Ocular Hypertension
  ClinicalTrials.gov Identifier: NCT00219596 - Completed
  Glaucoma, Open Angle; Ocular Hypertension
  
• A 6-week safety and efficacy study of Travatan compared to Xalcom in subjects with open-angle glaucoma(OAG) or ocular hypertension(OHT)
  ClinicalTrials.gov Identifier: NCT00051155 - Completed
  Glaucoma, Open-Angle; Ocular Hypertension
  
• Efficacy And Safety Of Xalatan Compared To Usual Care In Patients With Open Angle Glaucoma Or Ocular Hypertension.
  ClinicalTrials.gov Identifier: NCT00140062 - Completed
  Ocular Hypertension; Glaucoma, Open-Angle